Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Jabe Wilson

Jabe Wilson

About the author:

Dr. Jabe Wilson has been chosen as one of the DataIQ 100 — a list of the most influential people in data-driven business. Recognized as a “titan” of data-driven business for his work with data and analytics, Jabe is showcased in his own page on DataIQ’s website


Posts by Jabe Wilson

Machine Learning Could Make Drug Discovery Faster, Cheaper, Better

Posted on November 6th, 2018 in Pharma R&D

The stats on the increasingly high cost (and low success rates) in drug discovery are always jarring. As Phee Waterfield of Binary District Journal reports:

  • Bringing a new drug to market is estimated to cost major pharma firms more than $4 billion
  • The process can take 10-15 years
  • Fewer than 10% actually make it to market

Continue reading “Machine Learning Could Make Drug Discovery Faster, Cheaper, Better” »

How Greater Collaboration and Access to Data can Help Tackle Rare Diseases

Posted on November 1st, 2018 in Pharma R&D

It is estimated that 30 million people in the United States alone are living with one of 7,000 rare diseases, this equates to 10% of the population. There is, however, little financial incentive for the pharmaceutical sector to develop new treatments for these diseases because of the small patient population each disease affects. Continue reading “How Greater Collaboration and Access to Data can Help Tackle Rare Diseases” »

Rare Disease Drug Repurposing Datathon Launching

Posted on September 28th, 2018 in Pharma R&D

Would you and your organization like to use your skills and expertise to help defeat rare diseases? On October 9, the Rare Disease Drug Repurposing Datathon is launching, offering data scientists a special opportunity Continue reading “Rare Disease Drug Repurposing Datathon Launching” »